Hello Bill. I would post a guess, but I have already been wrong. I predicted a partner announcement at the start of phase 3. I can't see how they can benefit by the delay, but I'd love to be wrong about that too! Also, if you have 30 min to kill, I'd love to know what you think about SNGX and the preliminary phase 2 results for the oral mucositis agent. The company market cap seems stupid cheap, or is it me that is stupid? I have been aggressively accumulating SNGX. Feel free to post any thoughts on the SNGX board, maybe I'll see you there.